E Fund Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Buy |
16,525
+7,416
| +81% | +$127K | 0.01% | 318 |
|
|
2025
Q1 | $581K | Buy |
9,109
+1,500
| +20% | +$95.7K | 0.03% | 209 |
|
|
2024
Q4 | $925K | Sell |
7,609
-1,107
| -13% | -$135K | 0.05% | 155 |
|
|
2024
Q3 | $1.09M | Sell |
8,716
-45
| -0.5% | -$5.62K | 0.06% | 136 |
|
|
2024
Q2 | $1.38M | Buy |
8,761
+5,276
| +151% | +$834K | 0.08% | 102 |
|
|
2024
Q1 | $451K | Sell |
3,485
-2,034
| -37% | -$263K | 0.03% | 172 |
|
|
2023
Q4 | $532K | Buy |
5,519
+1,705
| +45% | +$164K | 0.03% | 152 |
|
|
2023
Q3 | $462K | Buy |
3,814
+315
| +9% | +$38.2K | 0.04% | 133 |
|
|
2023
Q2 | $401K | Buy |
3,499
+815
| +30% | +$93.4K | 0.03% | 167 |
|
|
2023
Q1 | $370K | Sell |
2,684
-889
| -25% | -$123K | 0.03% | 194 |
|
|
2022
Q4 | $463K | Sell |
3,573
-449
| -11% | -$58.2K | 0.04% | 143 |
|
|
2022
Q3 | $445K | Sell |
4,022
-2,311
| -36% | -$256K | 0.04% | 150 |
|
|
2022
Q2 | $475K | Buy |
6,333
+2,887
| +84% | +$217K | 0.04% | 152 |
|
|
2022
Q1 | $269K | Buy |
+3,446
| New | +$269K | 0.01% | 237 |
|